NCT07007312 2026-04-09Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLKura Oncology, Inc.Phase 3 Recruiting1,300 enrolled
NCT05735184 2026-03-13A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLKura Oncology, Inc.Phase 1 Recruiting420 enrolled